News & Events

News Releases

Tarsus Pharmaceuticals, Inc. Schedules Conference Call and Webcast to Announce Saturn-1 Phase 2b/3 Pivotal Trial Results for TP-03 for the Treatment of Demodex Blepharitis
Jun 18, 2021
Tarsus Pharmaceuticals, Inc. Initiates Phase 1 Callisto Trial of TP-05, a Novel, Oral, Non-Vaccine Therapeutic for the Prevention of Lyme Disease
Jun 16, 2021
Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual Healthcare Conference
May 24, 2021
Tarsus Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business and Clinical Updates
May 11, 2021
Tarsus Pharmaceuticals, Inc. Initiates Saturn-2, Second Pivotal Phase 3 Trial Evaluating the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
May 06, 2021
Tarsus Pharmaceuticals, Inc. Announces FDA Acceptance of Investigational New Drug Application for TP-05 for Lyme Disease Prevention
May 04, 2021
Tarsus Pharmaceuticals, Inc. Presents Results of Pioneering Atlas Study at ARVO 2021 Annual Meeting Demonstrating the Functional and Psychosocial Impact of Demodex Blepharitis
May 03, 2021
Tarsus Pharmaceuticals, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
Apr 27, 2021
Tarsus Pharmaceuticals, Inc. Reports Full-Year 2020 Financial Results and Business and Clinical Updates
Mar 31, 2021
Tarsus Pharmaceuticals and LianBio Announce Strategic Partnership to Develop and Commercialize TP-03 in Greater China for the Treatment of Demodex Blepharitis and Meibomian Gland Disease
Mar 29, 2021

Upcoming Events

Tarsus Saturn-1 Pivotal Trial Topline Results
Jun 21, 2021 at 8:00 AM EDT
View Webcast
Add to Outlook
Add to Google Calendar

Past Events

Jefferies Virtual Healthcare Conference
Jun 02, 2021 at 3:00 PM EDT
View Webcast
BofA Securities 2021 Virtual Healthcare Conference
May 12, 2021 at 5:00 PM EDT
View Webcast
ICR Conference 2021
Jan 14, 2021 at 2:30 PM EST
View Webcast
Jefferies Virtual London Healthcare Conference
Nov 17, 2020 at 10:35 AM GMT
View Webcast